Amphastar To Get $60M In Settlement With Rivals
Amphastar Pharmaceuticals Inc. announced Wednesday it will receive nearly $60 million from two rival drug companies as part of a settlement to resolve an antitrust and patent suit....To view the full article, register now.
Already a subscriber? Click here to view full article